We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Sulforaphane Blocks Prostate Cancer by Stabilizing a DNA Methylation Pathway

By LabMedica International staff writers
Posted on 14 Mar 2012
Cancer researchers have identified another molecular pathway linked to inhibition of the growth of prostate cancer cells by sulforaphane.

Sulforaphane (SFN), an isothiocyanate derived from cruciferous vegetables, has been shown to block growth of prostate cancer cells without causing damage to normal prostate tissue. More...
SFN is an organosulfur compound that has been found to exhibit anticancer, antidiabetic, and antimicrobial properties in various experimental models. It is obtained from cruciferous vegetables such as broccoli, Brussels sprouts, or cabbages. The enzyme myrosinase transforms glucoraphanin, a glucosinolate, into sulforaphane upon damage to the plant (such as from chewing). Young sprouts of broccoli and cauliflower are particularly rich in glucoraphanin.

Investigators at Oregon State University (Corvallis, USA) had shown in previous studies that the modulation of epigenetic marks, such as inhibition of histone deacetylase (HDAC) enzymes, contributed to the antiproliferative effects of SFN. However, the effects of SFN on other common epigenetic marks such as DNA methylation have not been studied thoroughly.

As promoter hyper-methylation of cyclin D2, a major regulator of the cell cycle, has been shown to correlate with prostate cancer progression, and restoration of cyclin D2 expression exerts antiproliferative effects on prostate cancer cells; the current study was designed to investigate the effects of SFN on the DNA methylation status of cyclin D2 promoter, and how alteration in promoter methylation impacts cyclin D2 gene expression in prostate cancer cells.

Results published in the October 26, 2011, issue of the journal Clinical Epigenetics demonstrated the ability of SFN to modulate epigenetically cyclin D2 expression. SFN significantly decreased the expression of DNA methyltransferases (DNMTs), especially DNMT1 and DNMT3b. Furthermore, SFN significantly decreased methylation in cyclin D2 promoter regions containing c-Myc and multiple Sp1 binding sites. Reduced methlyation of cyclin D2 promoter corresponded to an increase in cyclin D2 transcript levels, suggesting that SFN may de-repress methylation-silenced cyclin D2 by impacting epigenetic pathways.

“It appears that DNA methylation and HDAC inhibition, both of which can be influenced by sulforaphane, work in concert with each other to maintain proper cell function,” said senior author Dr. Emily Ho, associate professor of nutrition and exercise sciences at Oregon State University. “They sort of work as partners and talk to each other. With these processes, the key is balance. DNA methylation is a natural process, and when properly controlled is helpful. But when the balance gets mixed up it can cause havoc, and that is where some of these critical nutrients are involved. They help restore the balance.”

“Cancer is very complex and it is usually not just one thing that has gone wrong,” said Dr. Ho. “It is increasingly clear that sulforaphane is a real multitasker. The more we find out about it, the more benefits it appears to have.”

Related Links:

Oregon State University




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Automated Urinalysis Solution
UN-9000
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.